AR014467A1 - Unidad de dosis farmaceutica oralmente administrable de un tamano superior a 7 mm que comprende una droga y un recubrimiento externo, un metodo paraseparar una unidad de dosis farmaceutica oralmente administrable a partir de un alimento co-administrado y el uso de una droga y un material de recubrim - Google Patents
Unidad de dosis farmaceutica oralmente administrable de un tamano superior a 7 mm que comprende una droga y un recubrimiento externo, un metodo paraseparar una unidad de dosis farmaceutica oralmente administrable a partir de un alimento co-administrado y el uso de una droga y un material de recubrimInfo
- Publication number
- AR014467A1 AR014467A1 ARP990100264A ARP990100264A AR014467A1 AR 014467 A1 AR014467 A1 AR 014467A1 AR P990100264 A ARP990100264 A AR P990100264A AR P990100264 A ARP990100264 A AR P990100264A AR 014467 A1 AR014467 A1 AR 014467A1
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaceutical dose
- dose unit
- drug
- administrable pharmaceutical
- food
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
Abstract
Unidad de dosis farmacéutica administrable por vía oral de un tamano superior a 7 mm que comprende una droga y un recubrimiento externo que estáadaptado para evitar la liberacion de dicha droga en el estomago o en el intestino delgado cuando la unidad de dosis farmacéutica está en presencia dealimento; unidad de dosis farmacéutica administrable por vía oral de un tamano superior a los 7 mm que comprende una droga y un recubrimiento externo donde elrecubrimiento está constituido por un material que es soluble a valores de pH por debajo de 5,0 y que está adaptado para proveer una separacion de la unidadde dosis farmacéutica desde el material alimenticio co-administrado; método para separar una unidad de dosis farmacéuticaoralmente administrable a partirde un alimento co-administrado y uso de una droga y un material de recubrimiento para la manufactura de dichas unidades de dosis farmacéuticas.Preferiblemente la unidad de dosis farmacéutica está en formade una cápsula o tableta recubierta. Convenientemente el recubrimiento externo es un polímero.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9801363.4A GB9801363D0 (en) | 1998-01-22 | 1998-01-22 | Novel dosage form |
Publications (1)
Publication Number | Publication Date |
---|---|
AR014467A1 true AR014467A1 (es) | 2001-02-28 |
Family
ID=10825713
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP990100264A AR014467A1 (es) | 1998-01-22 | 1999-01-22 | Unidad de dosis farmaceutica oralmente administrable de un tamano superior a 7 mm que comprende una droga y un recubrimiento externo, un metodo paraseparar una unidad de dosis farmaceutica oralmente administrable a partir de un alimento co-administrado y el uso de una droga y un material de recubrim |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1059918A1 (es) |
JP (1) | JP2002501016A (es) |
AR (1) | AR014467A1 (es) |
AU (1) | AU2176099A (es) |
CA (1) | CA2318257A1 (es) |
GB (1) | GB9801363D0 (es) |
NO (1) | NO20003640L (es) |
WO (1) | WO1999037290A1 (es) |
ZA (1) | ZA99454B (es) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9910773D0 (en) * | 1999-05-11 | 1999-07-07 | West Pharm Serv Drug Res Ltd | Novel single unit coated dosage forms that can be used to minimise the effect of food on the absorption of drugs from the gastrointestinal tract |
GB0102342D0 (en) * | 2001-01-30 | 2001-03-14 | Smithkline Beecham Plc | Pharmaceutical formulation |
WO2006020009A1 (en) * | 2004-07-23 | 2006-02-23 | The Procter & Gamble Company | Solid oral dosage form of a bisphosphonate containing a chelating agent |
SI1889198T1 (sl) | 2005-04-28 | 2015-02-27 | Proteus Digital Health, Inc. | Farma-informacijski sistem |
US8802183B2 (en) | 2005-04-28 | 2014-08-12 | Proteus Digital Health, Inc. | Communication system with enhanced partial power source and method of manufacturing same |
US8836513B2 (en) | 2006-04-28 | 2014-09-16 | Proteus Digital Health, Inc. | Communication system incorporated in an ingestible product |
US8912908B2 (en) | 2005-04-28 | 2014-12-16 | Proteus Digital Health, Inc. | Communication system with remote activation |
US9198608B2 (en) | 2005-04-28 | 2015-12-01 | Proteus Digital Health, Inc. | Communication system incorporated in a container |
CN101496042A (zh) | 2006-05-02 | 2009-07-29 | 普罗秋斯生物医学公司 | 患者定制的治疗方案 |
EP2083680B1 (en) | 2006-10-25 | 2016-08-10 | Proteus Digital Health, Inc. | Controlled activation ingestible identifier |
US8718193B2 (en) | 2006-11-20 | 2014-05-06 | Proteus Digital Health, Inc. | Active signal processing personal health signal receivers |
ES2930588T3 (es) | 2007-02-01 | 2022-12-19 | Otsuka Pharma Co Ltd | Sistemas de marcador de eventos ingeribles |
KR101528748B1 (ko) | 2007-02-14 | 2015-06-15 | 프로테우스 디지털 헬스, 인코포레이티드 | 고 표면적 전극을 갖는 체내 전원 |
EP2124725A1 (en) | 2007-03-09 | 2009-12-02 | Proteus Biomedical, Inc. | In-body device having a multi-directional transmitter |
US9270025B2 (en) | 2007-03-09 | 2016-02-23 | Proteus Digital Health, Inc. | In-body device having deployable antenna |
US8115618B2 (en) | 2007-05-24 | 2012-02-14 | Proteus Biomedical, Inc. | RFID antenna for in-body device |
DK2192946T3 (da) | 2007-09-25 | 2022-11-21 | Otsuka Pharma Co Ltd | Kropsintern anordning med virtuel dipol signalforstærkning |
SG190590A1 (en) | 2007-11-27 | 2013-06-28 | Proteus Digital Health Inc | Transbody communication systems employing communication channels |
ES2840773T3 (es) | 2008-03-05 | 2021-07-07 | Otsuka Pharma Co Ltd | Sistemas y marcadores de eventos ingeribles de comunicación multimodo |
SG195535A1 (en) | 2008-07-08 | 2013-12-30 | Proteus Digital Health Inc | Ingestible event marker data framework |
US8540633B2 (en) | 2008-08-13 | 2013-09-24 | Proteus Digital Health, Inc. | Identifier circuits for generating unique identifiable indicators and techniques for producing same |
JP2012514799A (ja) | 2009-01-06 | 2012-06-28 | プロテウス バイオメディカル インコーポレイテッド | 摂取に関連するバイオフィードバックおよび個別薬物療法の方法およびシステム |
US8540664B2 (en) | 2009-03-25 | 2013-09-24 | Proteus Digital Health, Inc. | Probablistic pharmacokinetic and pharmacodynamic modeling |
WO2010129288A2 (en) | 2009-04-28 | 2010-11-11 | Proteus Biomedical, Inc. | Highly reliable ingestible event markers and methods for using the same |
WO2010132331A2 (en) | 2009-05-12 | 2010-11-18 | Proteus Biomedical, Inc. | Ingestible event markers comprising an ingestible component |
TWI517050B (zh) | 2009-11-04 | 2016-01-11 | 普羅托斯數位健康公司 | 供應鏈管理之系統 |
AU2011237612B2 (en) * | 2010-04-07 | 2016-05-12 | Otsuka Pharmaceutical Co., Ltd. | Miniature ingestible device |
TWI557672B (zh) | 2010-05-19 | 2016-11-11 | 波提亞斯數位康健公司 | 用於從製造商跟蹤藥物直到患者之電腦系統及電腦實施之方法、用於確認將藥物給予患者的設備及方法、患者介面裝置 |
WO2012071280A2 (en) | 2010-11-22 | 2012-05-31 | Proteus Biomedical, Inc. | Ingestible device with pharmaceutical product |
WO2015112603A1 (en) | 2014-01-21 | 2015-07-30 | Proteus Digital Health, Inc. | Masticable ingestible product and communication system therefor |
US9756874B2 (en) | 2011-07-11 | 2017-09-12 | Proteus Digital Health, Inc. | Masticable ingestible product and communication system therefor |
MX340001B (es) | 2011-07-21 | 2016-06-20 | Proteus Digital Health Inc | Dispositivo, sistema y método de comunicación móvil. |
US9235683B2 (en) | 2011-11-09 | 2016-01-12 | Proteus Digital Health, Inc. | Apparatus, system, and method for managing adherence to a regimen |
RU2015105699A (ru) | 2012-07-23 | 2016-09-10 | Протеус Диджитал Хелс, Инк. | Способы получения проглатываемых маркеров событий, содержащих проглатываемый компонент |
JP5869736B2 (ja) | 2012-10-18 | 2016-02-24 | プロテウス デジタル ヘルス, インコーポレイテッド | 通信デバイス用の電源において電力消失およびブロードキャスト電力を適応的に最適化するための装置、システム、および方法 |
TWI659994B (zh) | 2013-01-29 | 2019-05-21 | 美商普羅托斯數位健康公司 | 高度可膨脹之聚合型薄膜及包含彼之組成物 |
JP5941240B2 (ja) | 2013-03-15 | 2016-06-29 | プロテウス デジタル ヘルス, インコーポレイテッド | 金属検出器装置、システム、および方法 |
EP3005281A4 (en) | 2013-06-04 | 2017-06-28 | Proteus Digital Health, Inc. | System, apparatus and methods for data collection and assessing outcomes |
US9796576B2 (en) | 2013-08-30 | 2017-10-24 | Proteus Digital Health, Inc. | Container with electronically controlled interlock |
US10084880B2 (en) | 2013-11-04 | 2018-09-25 | Proteus Digital Health, Inc. | Social media networking based on physiologic information |
US11051543B2 (en) | 2015-07-21 | 2021-07-06 | Otsuka Pharmaceutical Co. Ltd. | Alginate on adhesive bilayer laminate film |
BR112019000861B1 (pt) | 2016-07-22 | 2020-10-27 | Proteus Digital Health, Inc | dispositivo eletrônico |
CA3041041A1 (en) | 2016-10-26 | 2018-05-03 | Proteus Digital Health, Inc. | Methods for manufacturing capsules with ingestible event markers |
US11458104B1 (en) * | 2018-06-21 | 2022-10-04 | Mission Pharmacal Company | Enteric coated tiopronin tablet |
CN109453166B (zh) * | 2018-10-16 | 2021-03-12 | 丹诺医药(苏州)有限公司 | 一种利福霉素-喹嗪酮偶联分子的固体分散体及其应用 |
CN110613697A (zh) * | 2019-10-30 | 2019-12-27 | 长春迪瑞制药有限公司 | 一种头孢氨苄胶囊及制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4786508A (en) * | 1986-05-30 | 1988-11-22 | Warner-Lambert Company | Coated dosage forms |
FR2618331B1 (fr) * | 1987-07-23 | 1991-10-04 | Synthelabo | Compositions pharmaceutiques utiles pour le traitement de l'uremie |
NZ228557A (en) * | 1988-04-05 | 1990-11-27 | Kyowa Hakko Kogyo Kk | Coating agent for delaying the release of active agents to be administered per os to ruminants, and veterinary compositions |
-
1998
- 1998-01-22 GB GBGB9801363.4A patent/GB9801363D0/en not_active Ceased
-
1999
- 1999-01-20 AU AU21760/99A patent/AU2176099A/en not_active Abandoned
- 1999-01-20 JP JP2000528272A patent/JP2002501016A/ja active Pending
- 1999-01-20 EP EP99901758A patent/EP1059918A1/en not_active Withdrawn
- 1999-01-20 CA CA002318257A patent/CA2318257A1/en not_active Abandoned
- 1999-01-20 WO PCT/GB1999/000193 patent/WO1999037290A1/en not_active Application Discontinuation
- 1999-01-21 ZA ZA9900454A patent/ZA99454B/xx unknown
- 1999-01-22 AR ARP990100264A patent/AR014467A1/es unknown
-
2000
- 2000-07-14 NO NO20003640A patent/NO20003640L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1059918A1 (en) | 2000-12-20 |
NO20003640L (no) | 2000-09-12 |
ZA99454B (en) | 2000-10-23 |
NO20003640D0 (no) | 2000-07-14 |
AU2176099A (en) | 1999-08-09 |
WO1999037290A1 (en) | 1999-07-29 |
CA2318257A1 (en) | 1999-07-29 |
GB9801363D0 (en) | 1998-03-18 |
JP2002501016A (ja) | 2002-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR014467A1 (es) | Unidad de dosis farmaceutica oralmente administrable de un tamano superior a 7 mm que comprende una droga y un recubrimiento externo, un metodo paraseparar una unidad de dosis farmaceutica oralmente administrable a partir de un alimento co-administrado y el uso de una droga y un material de recubrim | |
AR028299A1 (es) | Una composicion farmaceutica que comprende nateglinida, un proceso para su preparacion y el uso de dicha composicion para la preparacion de un medicamento para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condicion asociada con diabetes. | |
HUP9904174A2 (hu) | Bőrön át történő adagoláshoz szánt gyógyszerkészítmények | |
BR0107565A (pt) | Formas de dosagem de benzimidazol substituìdo e método de emprego das mesmas | |
BR9506028A (pt) | Forma farmacêutica oral de múltipla dosagem unitária em tablete processos para a preparação da mesma para a inibição da secreção de ácido gástrico em mamiferos e no homem e para o tratamento das doenças inflamatórias gastrointestinais em mamiíferos e no homem e embalagem de ampola de pressão transversal | |
SE8304393L (sv) | Naproxen- och naproxennatriumtabletter av controlled release-typ | |
AR018582A1 (es) | Forma de dosificacion en tableta para administrar un antagonista de los receptores de los leucotrienos y su uso en la preparacion de medicamentos | |
WO2006102446A3 (en) | Multi-particulate, modified-released colonic composition | |
MX9500885A (es) | Preparacion farmaceutica para administracion oral. | |
GR1002564B (el) | Στερεα απο του στοματος χορηγουμενη φαρμακευτικη μορφη δοσιμετρησεως προγραμματισμενου ρυθμου απελευθερωσεως. | |
DE69620606D1 (de) | Feste oral anzuwendende arzeneiform | |
BR0110038A (pt) | Comprimido de liberação controlada de multicamada, e, método para tratar a doença de parkinson | |
MX9203444A (es) | Medicamentos. | |
AU1227899A (en) | Osmotic medicament releasing system | |
CA2065809A1 (en) | Gastroresistant pharmaceutical formulations for oral administration containing salts of bile acids | |
NZ507566A (en) | Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants | |
WO2006040779A3 (en) | Controlled release gastric floating matrix formulation containing imatinib | |
RS50937B (sr) | Farmaceutska kompozicija koja sadrži metformin i glibenklamid za lečenje šećerne bolesti tipa ii | |
NO992944L (no) | Virkestoffbµrer for avgivelse av apomorfin i munnhulen | |
BR0012981A (pt) | Sistema para liberação oral de droga hidrodinamicamente balanceado | |
RU99118887A (ru) | Применение ингибиторов желудочно-кишечной липазы | |
CA2065652A1 (en) | Controlled release gastroresistant pharmaceutical formulations for oral administration containing bile acids and their salts | |
UA27848C2 (uk) | Лікарська форма, що перорально вводиться, для лікування центральних станів дефіциту допаміну | |
AR020803A1 (es) | Una composicion que comprende fexofenadina o una sal farmaceuticamente aceptable de la misma y el uso de la misma para la manufactura de unmedicamento | |
ATE260645T1 (de) | Agitationsunabhängige pharmazeutische multiple- unit-retardzubereitungen und verfahren zu ihrer herstellung |